Marshall Financial Group (Maryland)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.32M | Buy |
2,414
+128
| +6% | +$69.8K | 0.26% | 82 |
|
2025
Q1 | $960K | Buy |
2,286
+290
| +15% | +$122K | 0.21% | 115 |
|
2024
Q4 | $825K | Buy |
1,996
+112
| +6% | +$46.3K | 0.2% | 129 |
|
2024
Q3 | $952K | Buy |
1,884
+30
| +2% | +$15.2K | 0.23% | 122 |
|
2024
Q2 | $903K | Buy |
1,854
+135
| +8% | +$65.8K | 0.25% | 105 |
|
2024
Q1 | $928K | Buy |
1,719
+154
| +10% | +$83.1K | 0.27% | 103 |
|
2023
Q4 | $869K | Buy |
1,565
+216
| +16% | +$120K | 0.28% | 100 |
|
2023
Q3 | $590K | Buy |
1,349
+45
| +3% | +$19.7K | 0.21% | 117 |
|
2023
Q2 | $655K | Buy |
1,304
+75
| +6% | +$37.7K | 0.22% | 113 |
|
2023
Q1 | $615K | Buy |
+1,229
| New | +$615K | 0.22% | 122 |
|
2022
Q4 | – | Sell |
-1,728
| Closed | -$563K | – | 184 |
|
2022
Q3 | $563K | Buy |
1,728
+20
| +1% | +$6.52K | 0.24% | 126 |
|
2022
Q2 | $599K | Buy |
1,708
+260
| +18% | +$91.2K | 0.24% | 129 |
|
2022
Q1 | $792K | Buy |
1,448
+10
| +0.7% | +$5.47K | 0.32% | 114 |
|
2021
Q4 | $947K | Buy |
1,438
+182
| +14% | +$120K | 0.35% | 106 |
|
2021
Q3 | $781K | Buy |
1,256
+70
| +6% | +$43.5K | 0.4% | 87 |
|
2021
Q2 | $749K | Buy |
+1,186
| New | +$749K | 0.4% | 78 |
|